Spectrum Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Spectrum Pharmaceuticals

10/11/2021 22:03

* Spectrum Pharmaceuticals Inc  SPPI.OQ  reported a quarterly
adjusted loss of 21 cents​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of 28 cents per share.
* Reported revenue was zero​;  analysts expected $516.67
thousand. 
* Spectrum Pharmaceuticals Inc's reported EPS for the quarter
was a loss of 21 cents​.
* The mean earnings estimate of analysts had fallen by
about 13.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Spectrum Pharmaceuticals Inc shares had fallen by 3.2% this
quarter and lost 38.1% so far this year.
* The company reported a quarterly loss of $33.08 million.
* Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 10 at 10:03 p.m.
 ​All figures in US dollars unless otherwise stated